Latest News & Features
Americas
The Japanese pharma company files complaint against Lupin Pharmaceuticals | Suit alleges patent infringement over the company’s proposed generic version of a key ALS drug. 2 January 2025
Americas
Key developments for the industry this year include a more pro-patent administration and USPTO changes, say Carla Ji-Eun Kim and Deborah Sterling of Sterne Kessler. 2 January 2025
Americas
In an incredibly competitive and complex landscape, intellectual property is a critical asset for pharmaceutical and biotech companies. 25 December 2024
Americas
Andrew Wells of HGF explores how the EU Clinical Trials Regulation is affecting lifecycle IP strategies, and offers guidance on protecting inventions arising during clinical development. 25 December 2024
Americas
Dispute stems from Amneal’s efforts to market generic version of Teva’s inhaler for treating asthma | Precedential decision could restrict how brand-name pharmaceutical companies use the Orange Book to extend market exclusivity. 24 December 2024
Americas
In this session, Will James and Tim Harris will discuss their personal experiences litigating life sciences cases before the UPC. They will share their substantive and procedural insights, as well as strategic considerations and pitfalls to avoid. 24 December 2024
Americas
The Unified Patent Court (UPC) opened for business in June 2023. In this session, Ravi Srinivasan, partner at JA Kemp, explains how UPC litigation has been shaping up over the past year and shares practical tips based on experiences so far. 24 December 2024
Americas
Massachusetts medical research company is awarded damages following a jury verdict that found a Japanese pharma had infringed on its patent | Patent relates to Duchenne muscular dystrophy treatment. 24 December 2024
Americas
Long-recognised, unwritten jurisdictional norms have seen questions of validity and infringement of registered IP rights reserved to the courts of the country of registration. 22 December 2024
Americas
Bethan Hopewell, Joel Coles, and Siddharth Kusumakar, partners at Powell Gilbert, discuss the significant developments in the European patent landscape in 2024, not only at the UPC but also at the EPO. 22 December 2024